These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 10868950)

  • 21. Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels.
    Sharma N; Crane A; Gonzalez G; Bryan J; Aguilar-Bryan L
    Kidney Int; 2000 Mar; 57(3):803-8. PubMed ID: 10720932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism.
    Light PE; Manning Fox JE; Riedel MJ; Wheeler MB
    Mol Endocrinol; 2002 Sep; 16(9):2135-44. PubMed ID: 12198249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
    Tucker SJ; Gribble FM; Zhao C; Trapp S; Ashcroft FM
    Nature; 1997 May; 387(6629):179-83. PubMed ID: 9144288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.
    Hansen JB
    Curr Med Chem; 2006; 13(4):361-76. PubMed ID: 16475928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA.
    Gribble FM; Proks P; Corkey BE; Ashcroft FM
    J Biol Chem; 1998 Oct; 273(41):26383-7. PubMed ID: 9756869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG; Kinsella JM; Campbell CM; Ashford ML
    Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological changes in pancreatic islets of KATP channel-deficient mice: the involvement of KATP channels in the survival of insulin cells and the maintenance of islet architecture.
    Winarto A; Miki T; Seino S; Iwanaga T
    Arch Histol Cytol; 2001 Feb; 64(1):59-67. PubMed ID: 11310506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    Yan FF; Lin CW; Cartier EA; Shyng SL
    Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Cartier EA; Conti LR; Vandenberg CA; Shyng SL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
    Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
    Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways.
    Straub SG; Cosgrove KE; Ammälä C; Shepherd RM; O'Brien RE; Barnes PD; Kuchinski N; Chapman JC; Schaeppi M; Glaser B; Lindley KJ; Sharp GW; Aynsley-Green A; Dunne MJ
    Diabetes; 2001 Feb; 50(2):329-39. PubMed ID: 11272144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
    Shindo T; Katayama Y; Horio Y; Kurachi Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of ATP-sensitive K+ channels as metabolic sensors: studies of Kir6.x null mice.
    Minami K; Miki T; Kadowaki T; Seino S
    Diabetes; 2004 Dec; 53 Suppl 3():S176-80. PubMed ID: 15561908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Y-26763: ATP-sensitive K+ channel activation and the inhibition of insulin release from human pancreatic beta-cells.
    Cosgrove KE; Straub SG; Barnes PD; Chapman J; Sharp GW; Dunne MJ
    Eur J Pharmacol; 2004 Feb; 486(2):133-9. PubMed ID: 14975702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
    Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
    EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.